Quick Answer
Edwards Lifesciences Corp reported Total Revenue of $6.07 billion for fiscal year 2025.
Edwards Lifesciences Corp Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $6.07B | +11.5% |
| 2024 | $5.44B | +8.6% |
| 2023 | $5.01B | +12.2% |
| 2022 | $4.46B | -14.7% |
| 2021 | $5.23B | +19.3% |
| 2020 | $4.39B | +0.9% |
| 2019 | $4.35B | +16.8% |
| 2018 | $3.72B | +8.4% |
| 2017 | $3.44B | +15.9% |
| 2016 | $2.96B | +18.8% |
| 2015 | $2.49B | +7.4% |
| 2014 | $2.32B | +13.6% |
| 2013 | $2.05B | +7.7% |
| 2012 | $1.90B | +13.2% |
| 2011 | $1.68B | +16.0% |
| 2010 | $1.45B | +9.5% |
| 2009 | $1.32B | +6.8% |
| 2008 | $1.24B | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.55B | +14.7% | +1.4% |
| June 30, 2025 | $1.53B | +11.9% | +8.5% |
| March 31, 2025 | $1.41B | +6.2% | +4.3% |
| September 30, 2024 | $1.35B | +8.9% | -1.1% |
| June 30, 2024 | $1.37B | +5.7% | +3.0% |
| March 31, 2024 | $1.33B | -8.9% | +7.0% |
| September 30, 2023 | $1.24B | -5.7% | -4.0% |
| June 30, 2023 | $1.30B | -5.7% | -11.2% |
- Edwards Lifesciences Corp showed an increase of +11.5% in Total Revenue compared to the prior fiscal year.
- Over the 2008–2025 period, Edwards Lifesciences Corp’s total revenue has grown by 390.2% (from $1.24 billion to $6.07 billion).
- The most recent figure is from Edwards Lifesciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: